Skip to main content

Day: April 8, 2025

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

DENVER, April 08, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that the U.S. Food and Drug Administration (FDA) has granted SeaStar Medical two new Breakthrough Device Designations for its Selective Cytopheretic Device (SCD) therapy. The two new Breakthrough Device Designations are indicated for the treatment of systemic inflammatory response in 1) adult patients undergoing cardiac surgery and 2) pediatric patients undergoing cardiac surgery towards prevention of post-operative adverse complications and outcomes. Approximately 15 percent of the estimated 300,000 adults that undergo cardiac surgery each year are considered high risk and,...

Continue reading

SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.

TAMPA, FL, April 08, 2025 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, announced the divestiture of its legacy Healthcare IT and Wholesale Operations subsidiaries Integra Pharma Solutions (IPS), Bonum Health, Inc., and Softell, Inc. to Tollo Health, Inc. for a total consideration of $5 million. The divestitures are part of a broader strategic realignment at the Company designed to sharpen operational focus and unlock long-term value. It is aligned with the Company’s commitment to streamline its core operations, optimize its portfolio, and...

Continue reading

Enphase Energy Expands in Europe with IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Power in Luxembourg

FREMONT, Calif., April 08, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, today announced the launch of its most powerful and versatile battery yet, the IQ® Battery 5P with FlexPhase, for customers in Luxembourg. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that is designed to deliver reliable backup power and supports three-phase electrical system applications, which is the predominant configuration for homes in Luxembourg. Enphase recently launched the FlexPhase battery in Germany, Austria, Switzerland. The IQ Battery 5P starts at 5 kWh of capacity and multiple units can be configured to provide up to 70 kWh. Each 5 kWh battery is designed to deliver continuous power...

Continue reading

Hanover Bank Unveils a Refreshed Logo to Reflect Commitment to Innovation and Growth

MINEOLA, N.Y., April 08, 2025 (GLOBE NEWSWIRE) — Hanover Bank, the bank subsidiary of Hanover Bancorp (Nasdaq “HNVR”) is excited to unveil its new logo, a brand identity refresh that embodies our continued evolution into a financial services leader recognized for delivering digital banking solutions with unparalleled service. Our new logo reflects a forward-thinking vision that builds on the values of trust, stability, and progress – values that have always been at the heart of Hanover Bank since our founding in 2009 – underscoring our commitment to innovation and tradition. “We take great pride in our legacy and the strong relationships we’ve built over the years, and this logo represents our commitment to propelling them forward as we deliver a more agile, innovative, and client-focused banking experience, reinforcing our leadership...

Continue reading

CNB Financial Corporation Announces that ISS Recommends Shareholders Support the Proposal to Issue Common Stock in connection with the Merger with ESSA Bancorp, Inc., the Proposal to Approve the 2025 Omnibus Incentive Plan and the Say-on-Pay Proposal

CLEARFIELD, Pa., April 08, 2025 (GLOBE NEWSWIRE) — CNB Financial Corporation (“CNB”) (NASDAQ: CCNE) is pleased to announce that leading independent proxy advisory firm Institutional Shareholder Services Inc (“ISS”) is recommending that CNB shareholders vote “FOR” each of (1) the proposal to issue shares of CNB common stock in connection with the merger of ESSA Bancorp, Inc. (“ESSA”) with and into CNB; (2) the proposal to approve the CNB Financial Corporation 2025 Omnibus Incentive Plan; and (3) the non-binding advisory resolution to approve the compensation of CNB’s named executive officers in advance of the upcoming CNB Annual Meeting of Shareholders (the “Annual Meeting”). The Annual Meeting will be held at 2:00 p.m., Eastern Time, on Tuesday, April 15, 2025. Shareholders of record as of February 18, 2025 will be able to attend...

Continue reading

Shimmick Announces Chief Financial Officer Transition

Todd Yoder Appointed Executive Vice President and Chief Financial Officer Interim Chief Financial Officer Amanda Mobley Appointed Chief Accounting Officer IRVINE, Calif., April 08, 2025 (GLOBE NEWSWIRE) — Shimmick Corporation (“Shimmick” or the “Company”) (Nasdaq: SHIM), a leading infrastructure solutions provider specializing in complex water, climate resilience, energy transition, and sustainable transportation projects, today announced the appointment of Todd Yoder as Executive Vice President (“EVP”) and Chief Financial Officer (“CFO”), effective April 14, 2025. Amanda Mobley, interim CFO, has been appointed Chief Accounting Officer. “We are excited to welcome Todd to Shimmick as EVP & CFO,” said Ural Yal, Chief Executive Officer of Shimmick. “Todd brings extensive financial leadership experience within the construction...

Continue reading

Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies

BOSTON, April 08, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be hosting a virtual investor event on Friday, May 2, 2025 from 10:00 a.m. to 11:30 a.m. EDT. The webinar, hosted by the Praxis management team, will focus on the company’s clinical programs in developmental and epileptic encephalopathies (DEEs) including:The EMBOLD study evaluating relutrigine for SCN2A and SCN8A DEEs The EMERALD study evaluating relutrigine for broader DEEs The EMBRAVE3 study evaluating elsunersen for SCN2A gain-of-function DEETo RSVP and attend the live event, you may click here.  ...

Continue reading

TopBuild to Release First Quarter 2025 Results on Tuesday, May 6

Conference Call and Webcast at 9:00 A.M. ET DAYTONA BEACH, Fla., April 08, 2025 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, will release its first quarter 2025 results prior to 7:00 a.m. on Tuesday, May 6. The Company will host a conference call at 9:00 a.m. Eastern time that same day to review its financial results. To participate in the live call, dial 1-877-407-9037 or internationally 1-201-493-6738 approximately ten minutes before the scheduled call time. A live, listen-only webcast can be accessed at BLD Q1 2025 Webcast or through the Company’s website at www.topbuild.com. About TopBuild TopBuild Corp., headquartered in Daytona Beach, Florida, is a leading installer and...

Continue reading

Cycurion, Inc. Expands Partnership with Journal Technologies, Secures $22 Million Contract with State Police Agency

FALLS CHURCH, Va., April 08, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU), a trailblazer in advanced cybersecurity and information technology solutions, today announces an expanded partnership with Journal Technologies, a leading provider of case management and operational solutions for justice agencies worldwide. Together, the companies have been awarded a $22 million multi-year contract to deliver a state-of-the-art criminal justice case management system to a State Police agency, reinforcing Cycurion’s leadership in securing critical justice infrastructure. The web-based solution, powered by Journal Technologies’ robust eSeries Framework platform, provides comprehensive case management, tracking, and reporting capabilities. Designed to streamline the initiation, planning, execution, control, and reporting of prosecution...

Continue reading

Asia Broadband Opens Registration For Plant Tours of Its Gold and Silver Ore Processing Facility Beginning May 1st In Etzatlan, Mexico

LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company’s has opened its registration process for plant tours beginning May 1st of its new gold and silver ore processing facility in Etzatlan, Mexico. AABB now invites all shareholders interested in a plant tour to submit their information to info@asiabroadbandinc.com with the subject line Plant Tour. The required information from each shareholder to qualify for the selection is full shareholder name, number of AABB shares held and a PDF copy of proof of AABB shares owned. For those shareholders selected, the Company will require their identification and other information for the helicopter transportation to the facility. The random selection process will be completed on April 14th and the Company...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.